SIGYN THERAPEUTICS, INC.: 10-Q filed 2019-11-12
What SIGYN THERAPEUTICS, INC. reported in its quarterly report filed 2019-11-12 (fiscal Q3 2019): 34 published measures, 95 facts as tagged in accession 0001213900-19-022978.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-12
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001213900-19-022978 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SIGYN THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 763,152 | USD | |
| At 2018-12-31 | 862,049 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 4,679,826 | USD | |
| At 2018-12-31 | 4,577,291 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -3,916,674 | USD | |
| At 2018-12-31 | -3,715,242 | USD | |
| At 2018-09-30 | -2,682,339 | USD | |
| At 2017-12-31 | -2,093,874 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 500 | USD | |
| At 2018-12-31 | 7,497 | USD | |
| At 2018-09-30 | 8,127 | USD | |
| At 2017-12-31 | 9,592 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -138,575 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -201,432 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -355,987 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,402,686 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -113,674 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -298,433 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 32,100 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 137,983 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 28,349 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 6,677 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 303,407 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 100,000 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -6,439 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -13,202,701 | USD | |
| At 2018-12-31 | -13,001,269 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 81,272,408 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 81,272,408 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 65,460,451 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 61,710,263 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 81,272,408 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 81,272,408 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 65,460,451 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 61,710,263 | shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 6,170 | USD | |
| At 2018-12-31 | 15,530 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 32,370 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 112,293 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -122,725 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -392,897 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -241,304 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -763,224 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 692,541 | USD | |
| At 2018-12-31 | 733,188 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 15,850 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 46,850 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 111,201 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 304,280 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 4,679,826 | USD | |
| At 2018-12-31 | 4,577,291 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 15,116 | USD | |
| At 2018-12-31 | 22,710 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 64,441 | USD | |
| At 2018-12-31 | 113,331 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 146,815 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 496,790 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 241,304 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 781,861 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 692,041 | USD | |
| At 2018-12-31 | 723,595 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 24,090 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 103,893 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 18,637 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 8,010 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 34,090 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 9,712 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 81,272,408 | shares | |
| At 2018-12-31 | 81,272,408 | shares | |
| At 2014-12-31 | 16,000,250 | shares |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 39,482 | USD | |
| At 2018-12-31 | 30,122 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -138,575 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -439,747 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -328,539 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,092,999 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -138,575 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -201,432 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -355,987 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,402,686 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 145,748 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 485,715 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 208,734 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 624,931 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 9,360 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 9,470 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -15,850 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -46,850 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -87,235 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -329,775 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | -8,628 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -31,554 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -2,545 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -7,594 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -61,311 | USD | 273 |
Inspect the source
- Entity
- SIGYN THERAPEUTICS, INC. / CIK 0001642159
- Captured
- 2026-09-21T17:22:56.950Z
- SEC response SHA-256
e0e4d7f4bb391730e2aba50a78fbec4c845e6f42106fcbd8cdabccf8b438da5e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001642159.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))